Successful desensitization to pomalidomide in a patient with POEMS syndrome with delayed-type hypersensitivity to immunomodulatory imid drugs

Leuk Lymphoma. 2019 Dec;60(12):3087-3089. doi: 10.1080/10428194.2019.1620945. Epub 2019 Jun 4.

Authors

Francesco Grandoni¹, Grégoire Stalder¹, Amélie Borgeat Kaeser², Camillo Ribi², Anne Cairoli¹, Sabine Blum¹

Affiliations

¹ Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
² Service of Immunology and Allergology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

PMID: 31161829
DOI: 10.1080/10428194.2019.1620945

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Biomarkers
Desensitization, Immunologic*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / etiology*
Drug Hypersensitivity / therapy*
Female
Humans
Hypersensitivity, Delayed / diagnosis
Hypersensitivity, Delayed / etiology*
Hypersensitivity, Delayed / therapy*
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Magnetic Resonance Imaging
POEMS Syndrome / complications*
POEMS Syndrome / diagnosis
POEMS Syndrome / drug therapy
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use
Treatment Outcome

Substances

Biomarkers
Immunologic Factors
Thalidomide
pomalidomide